5-Year Lung Cancer Survival & Early Diagnosis Rates Improve

In this year’s “State of Lung Cancer” report, we have some good news to celebrate:

- The national 5-year survival rate jumped 26% between 2017 and 2021.
- In the last five years, the national rate of cases diagnosed early — when lung cancer is most treatable — increased 11%.

This is clear progress reflecting years of research advancements and awareness campaigns that you’ve helped make possible through your unwavering support.

Here’s what you can do right now to keep that progress going:

- Take our two?minute Lung Cancer Risk Quiz or share it with a loved one.
- Join LUNG FORCE to boost research innovation, early detection and better treatment options for lung cancer patients.
- Double your lifesaving impact: Donations are matched in November during Lung Cancer Awareness Month.

Free COPD Webinar + New Patient Resources, One?On?One Help

November is COPD Awareness Month, so we are sharing resources to support and educate everyone who is impacted by this chronic and progressive lung disease.

- Join Dr. Jordan Lee at our free Living Well with COPD webinar on Wednesday, November 20.
- Get our new and improved COPD Action Plan, which provides easy-to-use symptom tracking for managing COPD.
- Get free, personalized, 1-on-1 education and support from our Lung Health Navigators.
- Take our free COPD Basics course.

COPD in the U.S.: At least 11 million people in the U.S. are living with COPD. However, COPD is thought to be underdiagnosed, with an estimated 18 million people showing evidence of impaired lung function consistent with COPD.
 
Monitoring Air Quality from Space

Two-thirds of U.S. counties have no air quality monitoring network in their communities, which puts lung health at risk for millions of people across the country. To increase public awareness about this data disparity and provide possible solutions, we recently released a new report, “Something in the Air: Bridging the Air Quality Data Gap with Satellite Technology”.

Learn more from our "State of the Air" 2024 Report:

- Health Impact of Air Pollution
- Cleanest Places to Live
- Most Polluted Places to Live

Top Lung News

- Understanding Bronchitis: A Doctor Answers Your FAQs

- Meet Our 2024?2025 Research Awardees

- November's Mission Moment
    
More Lung News

Leadership and Legacy: Harold’s Story

Harold Wimmer, the American Lung Association’s President & CEO, has a personal connection that drives his passion for our work, including his pledge to ensure this critical work continues through his legacy gift commitment.

“By leaving a gift in my will, I know I’ll be able to make an impact for future generations,” Harold shares.

Read Harold’s story and learn how you can create your lasting legacy that ensures our critical work for years to come.

Protecting Your Baby Against Severe RSV

Respiratory Syncytial Virus (RSV) is a common respiratory virus infecting nearly 100% of children by age 2.

Prevention options are available to help reduce hospitalization for babies. These options include an RSV vaccine, given during weeks 32 to 36 of pregnancy, or a preventive antibody for infants and some toddlers who are at increased risk.

Learn more about RSV prevention:

- RSV in Babies – a video where you can hear what impaired breathing sounds like.

- Protecting Your Baby Against Severe RSV – a fact sheet for parents.

- RSV Resources in Spanish webpage

Visit Lung.org/RSV for more information. Support for this program is provided by Sanofi.

Fight Flu This Virus Season

Flu can make anyone seriously ill, but some people are at increased risk of serious illness, including:

- adults aged 65+;
- individuals who are pregnant; and
- individuals living with certain chronic medical conditions, such as lung disease.

An annual flu shot is recommended for everyone aged 6 months and older.

The Lung Association has resources to help you fight flu this season:

- Facts About Flu blog article
- Flu Resource Library
- #FightFlu Social Media Toolkit

Learn more at www.Lung.org/prevent-flu. Support for this program is provided by CSL Seqirus.

Guidance for Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious condition causing abnormally high pressure in the blood vessels between the lungs and the heart. PH can be difficult to diagnose and treat.

The Lung Association and Pulmonary Hypertension Association gathered PH experts to provide guidance about the 2022 ESC and ERS Guidelines for diagnosis and treatment of PH.

You can improve your understanding of PH diagnosis and care by reading what the experts have to say and finding resources to support your patients living with PH.

Support for this program provided by Merck.